Sapna Syngal MD MPH
Director of Research, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute -- Co-Leader, Cancer Risk, Prevention, and Early Detection Program, Dana-Farber/Harvard Cancer Center -- Professor of Medicine, Harvard Medical School,
Join to View Full Profile
75 Francis StBrigham and Womens Hospital Division of GastroenterologBoston, MA 02115
Phone+1 617-632-5532
Fax+1 617-632-4088
Dr. Syngal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 1993 - 1996
Harvard School of Public HealthMPH, Epidemiology, Biostatistics, 1993 - 1996- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
McGill University Faculty of MedicineClass of 1990
Certifications & Licensure
MA State Medical License 1992 - 2027
Awards, Honors, & Recognition
- Association of American Physicians 2018-2019
- Elected Member The American Society for Clinical Investigation, 2009
- Super Doctor SuperDoctors.com
Clinical Trials
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) Start of enrollment: 2013 Oct 01
- The Cancer of the Pancreas Screening-5 CAPS5)Study Start of enrollment: 2014 Jan 06
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer Start of enrollment: 2023 Apr 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Neoplasia detection via colonic surveillance among young individuals with MSH6 and PMS2-associated Lynch Syndrome.Alicia Latham, Ying L Liu, Gillain Constantino, Matilde Borio, Sean McCoy
The American Journal of Gastroenterology. 2025-02-27 - Cancer Incidence and Mortality in Familial Adenomatous Polyposis Syndrome.Dan Feldman, Linda H Rodgers-Fouche, Chinedu Ukaegbu, Matthew B Yurgelun, Sapna Syngal
Diseases of the Colon and Rectum. 2025-02-11 - Comparison of PREMM5 and PREMMplus Risk Assessment Models to Identify Lynch Syndrome.Leah H Biller, Kate Mittendorf, Miki Horiguchi, Alyson Caruso, Anu Chittenden
JCO Precision Oncology. 2025-01-01
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Press Mentions
It’s in the BloodAugust 9th, 2024- FDA Approves New Blood Test for Colon Cancer ScreeningJuly 29th, 2024
- FDA Approves Blood Test to Screen for Colon CancerJuly 29th, 2024
- Join now to see all
Grant Support
- Inclusion of Diverse and Medically Underserved Populations in the Design and Implementation of the PREMMplus Patient-Facing AppDANA-FARBER CANCER INST2024–2029
- Inclusion of Diverse and Medically Underserved Populations in the Design and Implementation of the PREMMplus Patient-Facing AppDANA-FARBER CANCER INST2024–2029
- Great Lakes New England Clinical Validation CenterUNIVERSITY OF TX MD ANDERSON CAN CTR2000–2027
- Great Lakes New England Clinical Validation CenterUNIVERSITY OF TX MD ANDERSON CAN CTR2000–2027
- Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessmentDANA-FARBER CANCER INST2008–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
